Ross Hunter, CRNA | |
700 Scott And White Dr, College Station, TX 77845-6441 | |
(979) 207-0100 | |
Not Available |
Full Name | Ross Hunter |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 6 Years |
Location | 700 Scott And White Dr, College Station, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801383930 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | AP137807 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Baylor Scott & White Medical Center- College Stati | College station, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Scott And White Clinic | 8123923604 | 2131 |
News Archive
In the BMJ Groups blog, Amanda Glassman, director of the global health policy program at the Center for Global Development (CGD), and her colleagues at CGD examine "whether universal health coverage (UHC) as a post-2015 development goal is a good idea."
Scientists at the Princess Margaret Cancer Centre have discovered a function of the tumor suppressor gene PTEN that helps explain why certain promising therapies fail in many cancer patients, a finding that could aid in delivering tailored, personalized cancer medicine based on an individual's genetics.
Abviva, Inc., a biomedical company engaged in the development and commercialization of breast cancer-related applications of Mammastatin, announced that the Canadian Patent Office issued notice that it will be issuing patent application Number 2.267.095 within 12 weeks
Despite the mounting death toll of America's opioid crisis, only a minority of facilities that treat substance use disorders offer patients buprenorphine, naltrexone or methadone-the three FDA-approved medications for the long-term management of opioid use disorder, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health.
› Verified 5 days ago
Entity Name | Scott & White Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093779704 PECOS PAC ID: 8123923604 Enrollment ID: O20031223000640 |
News Archive
In the BMJ Groups blog, Amanda Glassman, director of the global health policy program at the Center for Global Development (CGD), and her colleagues at CGD examine "whether universal health coverage (UHC) as a post-2015 development goal is a good idea."
Scientists at the Princess Margaret Cancer Centre have discovered a function of the tumor suppressor gene PTEN that helps explain why certain promising therapies fail in many cancer patients, a finding that could aid in delivering tailored, personalized cancer medicine based on an individual's genetics.
Abviva, Inc., a biomedical company engaged in the development and commercialization of breast cancer-related applications of Mammastatin, announced that the Canadian Patent Office issued notice that it will be issuing patent application Number 2.267.095 within 12 weeks
Despite the mounting death toll of America's opioid crisis, only a minority of facilities that treat substance use disorders offer patients buprenorphine, naltrexone or methadone-the three FDA-approved medications for the long-term management of opioid use disorder, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health.
› Verified 5 days ago
Entity Name | Christus Good Shepherd Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760908404 PECOS PAC ID: 3779565544 Enrollment ID: O20040604000400 |
News Archive
In the BMJ Groups blog, Amanda Glassman, director of the global health policy program at the Center for Global Development (CGD), and her colleagues at CGD examine "whether universal health coverage (UHC) as a post-2015 development goal is a good idea."
Scientists at the Princess Margaret Cancer Centre have discovered a function of the tumor suppressor gene PTEN that helps explain why certain promising therapies fail in many cancer patients, a finding that could aid in delivering tailored, personalized cancer medicine based on an individual's genetics.
Abviva, Inc., a biomedical company engaged in the development and commercialization of breast cancer-related applications of Mammastatin, announced that the Canadian Patent Office issued notice that it will be issuing patent application Number 2.267.095 within 12 weeks
Despite the mounting death toll of America's opioid crisis, only a minority of facilities that treat substance use disorders offer patients buprenorphine, naltrexone or methadone-the three FDA-approved medications for the long-term management of opioid use disorder, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health.
› Verified 5 days ago
Entity Name | Scott & White Hospital Brenham |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295464949 PECOS PAC ID: 5799719787 Enrollment ID: O20220719002610 |
News Archive
In the BMJ Groups blog, Amanda Glassman, director of the global health policy program at the Center for Global Development (CGD), and her colleagues at CGD examine "whether universal health coverage (UHC) as a post-2015 development goal is a good idea."
Scientists at the Princess Margaret Cancer Centre have discovered a function of the tumor suppressor gene PTEN that helps explain why certain promising therapies fail in many cancer patients, a finding that could aid in delivering tailored, personalized cancer medicine based on an individual's genetics.
Abviva, Inc., a biomedical company engaged in the development and commercialization of breast cancer-related applications of Mammastatin, announced that the Canadian Patent Office issued notice that it will be issuing patent application Number 2.267.095 within 12 weeks
Despite the mounting death toll of America's opioid crisis, only a minority of facilities that treat substance use disorders offer patients buprenorphine, naltrexone or methadone-the three FDA-approved medications for the long-term management of opioid use disorder, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Ross Hunter, CRNA Po Box 844658, Dallas, TX 75284-4658 Ph: (254) 724-2111 | Ross Hunter, CRNA 700 Scott And White Dr, College Station, TX 77845-6441 Ph: (979) 207-0100 |
News Archive
In the BMJ Groups blog, Amanda Glassman, director of the global health policy program at the Center for Global Development (CGD), and her colleagues at CGD examine "whether universal health coverage (UHC) as a post-2015 development goal is a good idea."
Scientists at the Princess Margaret Cancer Centre have discovered a function of the tumor suppressor gene PTEN that helps explain why certain promising therapies fail in many cancer patients, a finding that could aid in delivering tailored, personalized cancer medicine based on an individual's genetics.
Abviva, Inc., a biomedical company engaged in the development and commercialization of breast cancer-related applications of Mammastatin, announced that the Canadian Patent Office issued notice that it will be issuing patent application Number 2.267.095 within 12 weeks
Despite the mounting death toll of America's opioid crisis, only a minority of facilities that treat substance use disorders offer patients buprenorphine, naltrexone or methadone-the three FDA-approved medications for the long-term management of opioid use disorder, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health.
› Verified 5 days ago
Mildred Guillermo Franco, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 700 Scott And White Dr, College Station, TX 77845 Phone: 979-207-0100 | |
Nicole Rae Morris, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 700 Scott And White Dr, College Station, TX 77845 Phone: 979-207-0100 | |
James Christopher Fine, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 700 Scott And White Dr, College Station, TX 77845 Phone: 979-207-0100 | |
Mr. Steven Christian Piwonka, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 700 Scott And White Dr, College Station, TX 77845 Phone: 979-207-0100 | |
Stephanie K Moore, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 700 Scott And White Dr, College Station, TX 77845 Phone: 979-207-0100 Fax: 979-207-2161 | |
Cody Rapp, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1604 Rock Prairie Rd, College Station, TX 77845 Phone: 979-764-5100 | |
Robin Green, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 700 Scott And White Dr, College Station, TX 77845 Phone: 979-207-0100 |